Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Claritev Corporation

CTEVNYSE
Healthcare
Medical - Healthcare Information Services
$23.40
$0.09(0.39%)
U.S. Market is Open • 12:31

Claritev Corporation Fundamental Analysis

Claritev Corporation (CTEV) shows moderate financial fundamentals with a PE ratio of -1.11, profit margin of -35.93%, and ROE of 31.86%. The company generates $1.0B in annual revenue with weak year-over-year growth of -3.21%.

Key Strengths

ROE31.86%
Cash Position13.19%
PEG Ratio-0.02

Areas of Concern

Operating Margin-0.52%
We analyze CTEV's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 462.4/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
462.4/100

We analyze CTEV's fundamental strength across five key dimensions:

Efficiency Score

Weak

CTEV struggles to generate sufficient returns from assets.

ROA > 10%
-6.85%

Valuation Score

Excellent

CTEV trades at attractive valuation levels.

PE < 25
-1.11
PEG Ratio < 2
-0.02

Growth Score

Weak

CTEV faces weak or negative growth trends.

Revenue Growth > 5%
-3.21%
EPS Growth > 10%
-16.91%

Financial Health Score

Excellent

CTEV maintains a strong and stable balance sheet.

Debt/Equity < 1
-45.69
Current Ratio > 1
1.21

Profitability Score

Weak

CTEV struggles to sustain strong margins.

ROE > 15%
31.86%
Net Margin ≥ 15%
-35.93%
Positive Free Cash Flow
No

Key Financial Metrics

Is CTEV Expensive or Cheap?

P/E Ratio

CTEV trades at -1.11 times earnings. This suggests potential undervaluation.

-1.11

PEG Ratio

When adjusting for growth, CTEV's PEG of -0.02 indicates potential undervaluation.

-0.02

Price to Book

The market values Claritev Corporation at -3.74 times its book value. This may indicate undervaluation.

-3.74

EV/EBITDA

Enterprise value stands at -10.19 times EBITDA. This is generally considered low.

-10.19

How Well Does CTEV Make Money?

Net Profit Margin

For every $100 in sales, Claritev Corporation keeps $-35.93 as profit after all expenses.

-35.93%

Operating Margin

Core operations generate -0.52 in profit for every $100 in revenue, before interest and taxes.

-0.52%

ROE

Management delivers $31.86 in profit for every $100 of shareholder equity.

31.86%

ROA

Claritev Corporation generates $-6.85 in profit for every $100 in assets, demonstrating efficient asset deployment.

-6.85%

Following the Money - Real Cash Generation

Operating Cash Flow

Claritev Corporation generates limited operating cash flow of $17.06M, signaling weaker underlying cash strength.

$17.06M

Free Cash Flow

Claritev Corporation generates weak or negative free cash flow of $-113.42M, restricting financial flexibility.

$-113.42M

FCF Per Share

Each share generates $-6.86 in free cash annually.

$-6.86

FCF Yield

CTEV converts -29.54% of its market value into free cash.

-29.54%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

-1.11

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-0.02

vs 25 benchmark

P/B Ratio

Price to book value ratio

-3.74

vs 25 benchmark

P/S Ratio

Price to sales ratio

0.40

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-45.69

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.21

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

31.86

vs 25 benchmark

ROA

Return on assets percentage

-0.07

vs 25 benchmark

ROCE

Return on capital employed

-0.00

vs 25 benchmark

How CTEV Stacks Against Its Sector Peers

MetricCTEV ValueSector AveragePerformance
P/E Ratio-1.1129.43 Better (Cheaper)
ROE3186.10%800.00% Excellent
Net Margin-35.93%-20145.00% (disorted) Weak
Debt/Equity-45.690.30 Strong (Low Leverage)
Current Ratio1.214.64 Neutral
ROA-6.85%-17936.00% (disorted) Weak

CTEV outperforms its industry in 3 out of 6 key metrics, particularly excelling in ROE, but lagging in Net Margin.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Claritev Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

61.24%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-28965.56%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-35.54%

Industry Style: Defensive, Growth, Innovation

Declining

Fundamental Analysis FAQ